JIC
SPPI

Joel Isaacson & Co’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Joel Isaacson & Co’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2
Closed – – 778
2016
Q1 		$0 Hold
2
– – ﹤0.01% 801
2015
Q4 		$0 Hold
2
– – ﹤0.01% 804
2015
Q3 		$0 Hold
2
– – ﹤0.01% 784
2015
Q2 		$0 Buy
+2
New +$13 ﹤0.01% 792
2014
Q4 		– Sell
-2
Closed – – 666
2014
Q3 		$0 Hold
2
– – ﹤0.01% 632
2014
Q2 		$0 Hold
2
– – ﹤0.01% 590
2014
Q1 		$0 Buy
+2
New +$17 ﹤0.01% 586

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Joel Isaacson & Co's SPPI Position: Q2 2016 in Review

Joel Isaacson & Co sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2016, closing a stake of 2 shares.

Joel Isaacson & Co first reported a position in SPPI in Q1 2014 and held it in 7 quarters. The position peaked at $0 in Q1 2016. 161 funds tracked by Wall St. Rank hold SPPI as of Q2 2016.

  • Joel Isaacson & Co reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Joel Isaacson & Co sold 2 Spectrum Pharmaceuticals Inc shares in Q2 2016.
  • Joel Isaacson & Co first reported a position in Spectrum Pharmaceuticals Inc in Q1 2014 and held it in 7 quarters.
  • Joel Isaacson & Co's Spectrum Pharmaceuticals Inc position peaked at $0 in Q1 2016.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2016.

Based on Joel Isaacson & Co's 13F filing for Q2 2016, filed 22 Jul 2016.